![]() |
市場調查報告書
商品編碼
1625236
2030 年微藻類市場預測:按類型、類別、形式、等級、應用、分銷管道和地區進行的全球分析Microalgae Market Forecasts to 2030 - Global Analysis By Type (Spirulina, Chlorella, Haematococcus Pluvialis, Dunaliella Salina and Other Types), Category (Organic and Inorganic), Form, Grade, Application, Distribution Channel and By Geography |
根據 Stratistics MRC 的數據,2024 年全球微藻類市場規模為 127 億美元,預計到 2030 年將達到 207 億美元,預測期內複合年成長率為 8.4%。
微藻類被認為是在淡水和海洋棲息地中發現的最小的光合作用動物。這些生物是生態系統的基礎,產生氧氣並在水生食物網中佔據重要地位。它營養豐富且易於補充,可作為可再生生質燃料、營養補充劑、化妝品和藥物成分。微藻類可以固定二氧化碳,有助於緩解氣候變化,對於環境和工業應用至關重要。
據美國能源局(DOE) 稱,美國微藻類的潛在生質能產量估計為每年 1.52 億噸(無灰乾重)。
增強健康意識
消費者健康意識的提高是微藻類市場的主要驅動力。微藻類作為保健補充劑和機能性食品很受歡迎,因為它們富含蛋白質、維生素和Omega-3脂肪酸等必需營養素。人們對植物性飲食和天然食品成分的日益偏好進一步支持了這一趨勢。隨著人們對微藻類健康益處的認知不斷增強,預計各行業對這些產品的需求將會增加。
生產成本高
高生產成本仍是微藻類市場的主要限制因素。微藻類的培養和加工需要先進的技術、受控的環境和大量的能源輸入,從而導致營運成本增加。這些成本往往轉嫁給消費者,限制了市場滲透,特別是在價格敏感地區。透過技術進步和規模經濟降低生產成本對於克服這項挑戰和擴大市場至關重要。
藥品和化妝品領域的擴張
微藻類在藥品和化妝品中的廣泛應用為市場成長提供了利潤豐厚的機會。微藻類衍生的化合物,如抗氧化劑和生物活性胜肽,由於其抗衰老和癒合特性,擴大用於護膚產品和治療配方中。這些產業對天然和永續成分不斷成長的需求正在推動對基於微藻類的解決方案的進一步創新和投資,為市場擴張創造新的途徑。
缺乏標準化
微藻類培育、加工和品質評估缺乏標準化對市場構成重大威脅。產品品質的變化可能會削弱消費者的信心並阻礙監管部門的核准,特別是對於食品和藥品應用。建立標準化實踐和認證對於確保一致性、提高產品可靠性以及促進整個產業廣泛採用微藻類衍生產品至關重要。
隨著消費者越來越重視健康和增強免疫力的產品,COVID-19 大流行對微藻類市場產生了正面影響。在此期間,對含有微藻類的營養補充品的需求激增。此外,傳統食品供應鏈的中斷凸顯了微藻類等替代蛋白質來源的潛力。這些因素共同加速了微藻類類產品在各領域的採用。
食品和飲料行業預計將在預測期內成為最大的行業。
由於擴大使用微藻類作為保健食品、食品和飲料以及營養補充劑中的功能成分,食品和飲料領域預計將主導市場。其高營養價值使其成為滿足消費者對天然植物來源產品需求的理想選擇。將微藻類納入主流食品應用的技術創新將進一步推動這一領域的成長。
預計小球藻細分市場在預測期內的複合年成長率最高。
小球藻細分市場預計將表現出最高的複合年成長率,因為它具有廣泛的健康益處,例如解毒、免疫支持和改善消化。此外,高蛋白質含量使其成為素食的首選。小球藻在營養保健品、化妝品和飼料中的使用越來越多,強調了它在多種應用中的多功能性和快速成長潛力。
在預測期內,由於其成熟的水產養殖業和藻類產品的高消費量,預計亞太地區將佔據最大的市場佔有率。中國、日本和印度等國家正在透過對機能性食品、營養保健品和化妝品的強勁需求推動區域成長。此外,政府促進永續農業的措施進一步支持該地區的市場擴張。
由於消費者對微藻類相關健康益處的認知不斷提高,預計北美地區在預測期內將出現最高的成長率。該地區對植物性蛋白質和天然成分的強勁需求正在推動食品、飲料和營養補充劑的創新。此外,文化技術的進步也促進了北美市場的快速成長。
According to Stratistics MRC, the Global Microalgae Market is accounted for $12.7 billion in 2024 and is expected to reach $20.7 billion by 2030 growing at a CAGR of 8.4% during the forecast period. Microalgae are considered the smallest, photosynthetic animals in freshwater and marine habitats. These organisms are basics to ecological systems, capable of producing oxygen and holding a basic position in the aquatic food webs. They are highly nutrient-rich and they can easily be replenished as a raw material for renewable biofuels, dietary supplements, cosmetics, and pharmaceuticals. Capable of carbon dioxide fixation, microalgae contribute to climate change mitigation, making them vital for environmental and industrial applications.
According to the U.S. Department of Energy (DOE), the total microalgae biomass production potential in the United States is estimated at 152 million tons per year (ash-free dry weight).
Increasing health consciousness
The rising health consciousness among consumers has significantly driven the microalgae market. Microalgae are rich in essential nutrients, including proteins, vitamins, and omega-3 fatty acids, making them a popular choice for health supplements and functional foods. This trend is further supported by the growing preference for plant-based diets and natural food ingredients. As awareness of the health benefits of microalgae continues to grow, demand for these products is expected to rise across various industries.
High production costs
High production costs remain a significant restraint for the microalgae market. Cultivating and processing microalgae require advanced technologies, controlled environments, and substantial energy inputs, leading to increased operational expenses. These costs are often passed on to consumers, limiting market penetration, particularly in price-sensitive regions. Reducing production costs through technological advancements and economies of scale is essential to overcoming this challenge and expanding the market.
Expansion in pharmaceuticals and cosmetics
The growing application of microalgae in pharmaceuticals and cosmetics presents a lucrative opportunity for market growth. Microalgae-derived compounds, such as antioxidants and bioactive peptides, are increasingly used in skincare products and therapeutic formulations due to their anti-aging and healing properties. The rising demand for natural and sustainable ingredients in these sectors further drives innovation and investment in microalgae-based solutions, creating new avenues for market expansion.
Lack of standardization
The lack of standardization in microalgae cultivation, processing, and quality assessment poses a significant threat to the market. Variability in product quality can undermine consumer trust and hinder regulatory approvals, especially in food and pharmaceutical applications. Establishing standardized practices and certifications is critical to ensuring consistency, enhancing product credibility, and fostering wider adoption of microalgae-derived products across industries.
The COVID-19 pandemic positively impacted the microalgae market as consumers increasingly prioritized health and immunity-boosting products. The demand for dietary supplements containing microalgae surged during this period. Additionally, disruptions in traditional food supply chains highlighted the potential of alternative protein sources like microalgae. These factors collectively accelerated the adoption of microalgae-based products across various sectors.
The food & beverages segment is expected to be the largest during the forecast period
The food & beverages segment is expected to dominate the market due to the increasing use of microalgae as a functional ingredient in health foods, beverages, and dietary supplements. Its high nutritional value makes it an ideal choice for addressing consumer demand for natural and plant-based products. The segment's growth is further driven by innovations in incorporating microalgae into mainstream food applications.
The chlorella segment is expected to have the highest CAGR during the forecast period
The chlorella segment is expected to witness the highest CAGR due to its extensive health benefits, including detoxification, immune support, and improved digestion. Its high protein content also makes it a preferred choice for vegan diets. The increasing use of chlorella in dietary supplements, cosmetics, and animal feed highlights its versatility and potential for rapid growth across multiple applications.
Over the forecast period, the Asia Pacific region is anticipated to account for the largest market share due to its well-established aquaculture industry and high consumption of algae-based products. Countries like China, Japan, and India drive regional growth through their strong demand for functional foods, dietary supplements, and cosmetics. Additionally, government initiatives promoting sustainable agriculture further support market expansion in this region.
The North America region is anticipated to register the highest growth rate over the forecast period owing to increasing consumer awareness about health benefits associated with microalgae. The region's robust demand for plant-based proteins and natural ingredients drives innovation in food & beverages as well as nutraceuticals. Moreover, advancements in cultivation technologies contribute to the rapid growth of this market in North America.
Key players in the market
Some of the key players in Microalgae Market include DIC Corporation, Cyanotech Corporation, Corbion N.V., AlgaEnergy S.A., Cellana Inc., Euglena Co., Ltd., Algaecytes, Parry Nutraceuticals, Allmicroalgae, Kuehnle AgroSystems, Algatech, Algarithm, Sunrise Nutrachem Group Co., Ltd., BASF SE, Koninklijke DSM N.V., Solabia Group, TerraVia Holdings, Inc. and Roquette Freres.
In August 2024, Euglena Co., Ltd. signs with Petronas Research Sdn. Bhd. a subsidiary of Petroliam Nasional Berhad (hereafter "Petronas Research") that have entered into a Joint Development Agreement on August 21st , 2024 to implement a joint research with a mission to materialize the future large-scale commercial production of microalgae oil for SAF and other biofuels.
In July 2024, Parry Nutraceuticals, a division of EID Parry (I) Ltd, based in Chennai, has become a world leader and expert in micro-algal technology. Parry is the only micro-algal innovator in the world producing all three microalgae-spirulina, haematococcus (astaxanthin), and chlorella. The company works with ecologically sustainable cultivation practices that help preserve nutrients for optimum absorption.
In March 2024, Kuehnle AgroSystems ("KAS"), a leading microalgal innovation and production company, today announced that it has raised a $3 million Series A2 funding round led by S2G Ventures. The funding will accelerate the commercialization of KAS's pioneering method for producing natural astaxanthin from microalgae, a key component in sustainable aquaculture systems as well as a clinically proven human nutraceutical.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.